• Profile
Close

A randomized control trial of preoperative prophylactic antibiotics prior to percutaneous nephrolithotomy in low infectious risk population: A report from the EDGE consortium

The Journal of Urology Apr 27, 2018

Chew BH, et al. - Authors conducted a rigorous (using CONSORT guidelines), multi-institutional trial to evaluate preoperative antibiotics in prior to percutaneous nephrolithotomy (PCNL) patients at low risk of developing infections. In PCNL patients at “low risk” for infectious complications, no advantage of providing 1 week of preoperative oral antibiotics was seen. Experts noted the peri-operative antibiotics per the American Urological Association (AUA) Best Practice Statement to be sufficient.

Methods

  • Experts enrolled the “low risk” patients (negative pre-operative urine cultures and without any urinary drains) undergoing PCNL in a randomized controlled trial.
  • They randomized the subjects to nitrofurantoin 100 mg BID for 7 days preceding surgery (n=43) and control arm with no oral antibiotics (n=43).
  • Peri-operative doses of ampicillin and gentamicin was received by all subjects received.
  • Urologists blinded to randomization performed prone PCNL.
  • Development of sepsis was the primary outcome.

Results

  • As per results 86 subjects were enrolled.
  • Between treatment and control cohorts pre-operative patient characteristics were similar (stone size 19mm and 17mm, p=0.47).
  • No differences were demonstrated by intra-operative characteristics.
  • Findings suggested that the rate of sepsis was not statistically different between the treatment and control groups (12% and 14%, 95% CI [-0.163, 0.122], p=1.0).
  • Authors noted other infectious parameters and complications to be similar (intensive care admission, fever, hypotension, leukocytosis).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay